Shockwave Medical, Inc. (NASDAQ:SWAV) Shares Bought by Fisher Asset Management LLC

Fisher Asset Management LLC lifted its stake in Shockwave Medical, Inc. (NASDAQ:SWAV) by 0.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 76,078 shares of the company’s stock after acquiring an additional 417 shares during the period. Fisher Asset Management LLC’s holdings in Shockwave Medical were worth $14,498,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. Robbins Farley lifted its stake in shares of Shockwave Medical by 1.0% in the 4th quarter. Robbins Farley now owns 4,542 shares of the company’s stock worth $866,000 after acquiring an additional 45 shares during the period. Parallel Advisors LLC lifted its stake in shares of Shockwave Medical by 3.8% in the 4th quarter. Parallel Advisors LLC now owns 1,268 shares of the company’s stock worth $242,000 after acquiring an additional 47 shares during the period. Treasurer of the State of North Carolina lifted its stake in shares of Shockwave Medical by 0.4% in the 3rd quarter. Treasurer of the State of North Carolina now owns 16,390 shares of the company’s stock worth $3,263,000 after acquiring an additional 60 shares during the period. State of Michigan Retirement System lifted its stake in shares of Shockwave Medical by 1.1% in the 4th quarter. State of Michigan Retirement System now owns 8,900 shares of the company’s stock worth $1,696,000 after acquiring an additional 100 shares during the period. Finally, PNC Financial Services Group Inc. lifted its stake in shares of Shockwave Medical by 7.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 1,705 shares of the company’s stock worth $325,000 after acquiring an additional 112 shares during the period. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Shockwave Medical

In other Shockwave Medical news, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $287.67, for a total value of $1,150,680.00. Following the transaction, the insider now owns 56,818 shares in the company, valued at approximately $16,344,834.06. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other Shockwave Medical news, Director Laura Francis sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $300.00, for a total value of $450,000.00. Following the transaction, the director now owns 3,551 shares in the company, valued at approximately $1,065,300. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Isaac Zacharias sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $287.67, for a total transaction of $1,150,680.00. Following the completion of the transaction, the insider now owns 56,818 shares in the company, valued at approximately $16,344,834.06. The disclosure for this sale can be found here. Company insiders own 3.40% of the company’s stock.

Analysts Set New Price Targets

SWAV has been the subject of several recent research reports. Canaccord Genuity Group reissued a “hold” rating and set a $335.00 target price (up from $263.00) on shares of Shockwave Medical in a research note on Friday, April 5th. Morgan Stanley reissued an “equal weight” rating and set a $335.00 target price (up from $285.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Needham & Company LLC reissued a “hold” rating on shares of Shockwave Medical in a research note on Friday, April 5th. CL King reissued a “neutral” rating on shares of Shockwave Medical in a research note on Monday, April 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $335.00 target price (up from $270.00) on shares of Shockwave Medical in a research note on Monday, April 8th. Ten research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, Shockwave Medical presently has an average rating of “Hold” and a consensus target price of $309.11.

Shockwave Medical Price Performance

Shares of NASDAQ:SWAV opened at $334.75 on Wednesday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 12.61 and a current ratio of 13.81. The company has a market cap of $12.57 billion, a PE ratio of 78.21, a price-to-earnings-growth ratio of 2.43 and a beta of 0.88. Shockwave Medical, Inc. has a 52 week low of $157.00 and a 52 week high of $334.90. The firm has a 50 day simple moving average of $331.53 and a 200 day simple moving average of $271.17.

Shockwave Medical (NASDAQ:SWAV) last issued its quarterly earnings results on Monday, May 6th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $0.99 by $0.45. The business had revenue of $218.80 million during the quarter, compared to the consensus estimate of $207.69 million. Shockwave Medical had a net margin of 20.75% and a return on equity of 24.79%. The firm’s quarterly revenue was up 35.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.03 EPS. As a group, research analysts expect that Shockwave Medical, Inc. will post 5.05 earnings per share for the current year.

About Shockwave Medical

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.